Company continues to generate strong earnings and margins, announces process to assess strategic alternativesCompany to Host Conference Call Today at 9 a.m. ET MIAMI, Nov. 08, 2024 (GLOBE NEWSWIRE) -- ...
Over a series of conferences during the third quarter 2024, Ocugen had the opportunity to provide an update on its three clinical-stage modifier gene therapies to significant investor audiences as ...